日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results

使用 (177)Lu-FAP-2286 进行肽靶向放射性核素治疗多种腺癌的可行性、生物分布和初步剂量测定：首次人体试验结果

期刊:
影响因子:
doi:10.2967/jnumed.120.259192
Baum, Richard P; Schuchardt, Christiane; Singh, Aviral; Chantadisai, Maythinee; Robiller, Franz C; Zhang, Jingjing; Mueller, Dirk; Eismant, Alexander; Almaguel, Frankis; Zboralski, Dirk; Osterkamp, Frank; Hoehne, Aileen; Reineke, Ulrich; Smerling, Christiane; Kulkarni, Harshad R
Human
肿瘤
肿瘤免疫
FAP
发表日期：2022
文献求助 收藏

Novel Treatment of a Malignant Peripheral Nerve Sheath Tumor of the Median Nerve

正中神经恶性周围神经鞘瘤的新疗法

期刊:Plastic and Reconstructive Surgery-Global Open
影响因子:1.8
doi:10.1097/GOX.0000000000002011
Liodaki, Eirini; Robiller, Sandra; Wenzel, Eike; Mailaender, Peter; Stang, Felix
发表日期：2018
文献求助 收藏

Results and adverse events of personalized peptide receptor radionuclide therapy with (90)Yttrium and (177)Lutetium in 1048 patients with neuroendocrine neoplasms

1048 例神经内分泌肿瘤患者接受（90）钇和（177）镥个性化肽受体放射性核素治疗的结果和不良事件

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.24524
Baum, Richard P; Kulkarni, Harshad R; Singh, Aviral; Kaemmerer, Daniel; Mueller, Dirk; Prasad, Vikas; Hommann, Merten; Robiller, Franz C; Niepsch, Karin; Franz, Holger; Jochems, Arthur; Lambin, Philippe; Hörsch, Dieter
信号转导
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏